TARDBP and amyotrophic lateral sclerosis: For two of the studies, the ‘seed’ was derived from clinically confirmed ALS patient tissue showing TDP-43 positive inclusions, but the aggregates present have not been robustly characterised using biophysical techniques, and there is scope for heterogeneity between and within patient samples [27], [107].